Form SC 13G/A ALLERGAN INC Filed by: BlackRock Inc.

Go back to Form SC 13G/A ALLERGAN INC Filed by: BlackRock Inc.

Allergan (AGN) Tops Q4 EPS by 34c

February 4, 2015 4:31 PM EST

Allergan (NYSE: AGN) reported Q4 EPS of $2.17, $0.34 better than the analyst estimate of $1.83. Revenue for the quarter came in at $1.91 billion versus the consensus estimate of $1.9 billion.

For earnings history and earnings-related data on Allergan (AGN) click here.

... More